To evaluate whether PARD6A is clinically associated with ovarian cancers (serous, mucinous, and clear cell ovarian cancers), expression of PARD6A protein PAR6α were studied in patients’ tissues versus normal ovarian epithial tissues using immunohistochemistry assays (Fig. 1A, Table 1). This evidence concerns the gene PARD6A and ovarian carcinoma.